$IMVT
Immunovant, Inc. Stock $imvt

2019 Q4 Form 10-Q Financial Statement

Concept	2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$123.5M
YoY Change
Cash & Equivalents	$123.5M
Short-Term Investments
Other Short-Term Assets	$0.00
YoY Change
Inventory
Prepaid Expenses	$44.00K
Receivables
Other Receivables
Total Short-Term Assets	$126.6M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$49.00K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$0.00
YoY Change
Total Long-Term Assets	$49.00K
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$126.6M
Total Long-Term Assets	$49.00K
Total Assets	$126.6M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.812M
YoY Change
Accrued Expenses	$8.705M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$14.80M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$14.80M
Total Long-Term Liabilities	$0.00
Total Liabilities	$14.76M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings	-$70.68M
YoY Change
Common Stock	$5.000K
YoY Change	1636.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$111.9M
YoY Change
Total Liabilities & Shareholders Equity	$126.6M
YoY Change

Concept	2019 Q4
OPERATING ACTIVITIES
Net Income	-$11.30M
YoY Change	27.65%
Depreciation, Depletion And Amortization	$20.00K
YoY Change
Cash From Operating Activities	-$29.78M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures	-$20.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$115.0M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	30.05M
YoY Change
NET CHANGE
Cash From Operating Activities	-29.78M
Cash From Investing Activities	115.0M
Cash From Financing Activities	30.05M
Net Change In Cash	115.3M
YoY Change
FREE CASH FLOW
Cash From Operating Activities	-$29.78M
Capital Expenditures	-$20.00K
Free Cash Flow	-$29.76M
YoY Change

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	14375000	shares
	HSAC	Weighted Average Number Of Share Outstanding Non Redeemable Common Stock Basic And Diluted WeightedAverageNumberOfShareOutstandingNonRedeemableCommonStockBasicAndDiluted	2875000	shares
CY2019Q3	HSAC	Weighted Average Number Of Share Outstanding Non Redeemable Common Stock Basic And Diluted WeightedAverageNumberOfShareOutstandingNonRedeemableCommonStockBasicAndDiluted	2875000	shares